Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Are Beta-Blockers Still Relevant?
作者信息
Hyun Junho
机构信息
Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
出版信息
Int J Heart Fail. 2024 Jul 18;6(3):127-128. doi: 10.36628/ijhf.2024.0038. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Are Beta-Blockers Still Relevant?射血分数保留的心力衰竭与心房颤动：β受体阻滞剂仍然适用吗？
Int J Heart Fail. 2024 Jul 18;6(3):127-128. doi: 10.36628/ijhf.2024.0038. eCollection 2024 Jul.
2
Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry.β 受体阻滞剂与射血分数保留心力衰竭结局的相关性：来自瑞典心力衰竭注册研究的最新见解。
J Card Fail. 2021 Nov;27(11):1165-1174. doi: 10.1016/j.cardfail.2021.04.015. Epub 2021 May 8.
3
Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction.永久性希氏束起搏联合房室结消融治疗左心室射血分数保留和降低的心力衰竭伴心房颤动患者的获益。
J Am Heart Assoc. 2017 Apr 1;6(4):e005309. doi: 10.1161/JAHA.116.005309.
4
An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps.非二氢吡啶类钙通道阻滞剂和β受体阻滞剂在心房颤动及急性失代偿性心力衰竭中作用的最新综述：证据与差距
Cardiovasc Drugs Ther. 2023 Dec;37(6):1205-1223. doi: 10.1007/s10557-022-07334-y. Epub 2022 Mar 31.
5
Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.射血分数保留的心力衰竭伴或不伴心房颤动患者中心力衰竭合并射血分数降低患者指南依从性评估。
J Korean Med Sci. 2021 Oct 18;36(40):e252. doi: 10.3346/jkms.2021.36.e252.
6
Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial Fibrillation.心力衰竭伴射血分数降低合并心房颤动患者中钙通道阻滞剂使用趋势。
Am J Med. 2021 Nov;134(11):1413-1418.e1. doi: 10.1016/j.amjmed.2021.06.013. Epub 2021 Jul 7.
7
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.左心房容积和左心室质量指数在射血分数保留和降低的心力衰竭中的变化。
ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4.
8
Beta-blockers in atrial fibrillation-trying to make sense of unsettling results.β受体阻滞剂在心房颤动中的应用——试图理解令人不安的结果。
Europace. 2023 Feb 16;25(2):260-262. doi: 10.1093/europace/euad010.
9
[Heart failure with preserved ejection fraction].射血分数保留的心力衰竭
Vnitr Lek. 2016 Fall;62(7-8):646-51.
10
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.老年射血分数保留心力衰竭患者的临床特征和结局的性别差异：伊贝沙坦治疗射血分数保留心力衰竭（I-PRESERVE）试验。
Circ Heart Fail. 2012 Sep 1;5(5):571-8. doi: 10.1161/CIRCHEARTFAILURE.112.970061. Epub 2012 Aug 10.
本文引用的文献
1
Precision Cardiology: Phenotype-targeted Therapies for HFmrEF and HFpEF.精准心脏病学：射血分数保留的心力衰竭（HFpEF）和射血分数中间值的心力衰竭（HFmrEF）的靶向表型治疗
Int J Heart Fail. 2024 Mar 25;6(2):47-55. doi: 10.36628/ijhf.2023.0058. eCollection 2024 Apr.
2
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.HFmrEF 或 HFpEF 患者中β受体阻滞剂的现代应用及意义：DELIVER 试验。
JACC Heart Fail. 2024 Apr;12(4):631-644. doi: 10.1016/j.jchf.2023.09.007. Epub 2023 Sep 27.
3
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.韩国心力衰竭管理指南：治疗
Int J Heart Fail. 2023 Apr 10;5(2):66-81. doi: 10.36628/ijhf.2023.0011. eCollection 2023 Apr.
4
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
5
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.β受体阻滞剂撤药对射血分数保留的心力衰竭患者功能能力的影响。
J Am Coll Cardiol. 2021 Nov 23;78(21):2042-2056. doi: 10.1016/j.jacc.2021.08.073.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
7
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.房颤伴心力衰竭患者的早期节律控制治疗。
Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30.
8
Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.β受体阻滞剂在急性心力衰竭伴心房颤动患者出院时的应用。
J Korean Med Sci. 2020 Aug 24;35(33):e278. doi: 10.3346/jkms.2020.35.e278.
9
Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation.射血分数保留的心力衰竭（HFpEF）合并心房颤动患者使用β受体阻滞剂治疗可降低死亡率
Cardiol Res Pract. 2020 May 13;2020:3059864. doi: 10.1155/2020/3059864. eCollection 2020.
10
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.β受体阻滞剂的使用与射血分数保留的心力衰竭患者心力衰竭住院和心血管疾病死亡率的关系：TOPCAT 试验的二次分析。
JAMA Netw Open. 2019 Dec 2;2(12):e1916598. doi: 10.1001/jamanetworkopen.2019.16598.
Zotero 插件